These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6187635)

  • 1. [Development of blood donating in the DDR in the period 1972 to 1980].
    Marquordt-Schulze H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):836-42. PubMed ID: 6187635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
    Tozer RA
    P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Social structure of the donor sample of a district blood donation and transfusion institute].
    Uhlig R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):321-9. PubMed ID: 2475414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forecasting Ontario's blood supply and demand.
    Drackley A; Newbold KB; Paez A; Heddle N
    Transfusion; 2012 Feb; 52(2):366-74. PubMed ID: 21810099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimation of the blood donation necessary for self-sufficiency of blood products].
    Pinto V; Hernández Mejía R; Cueto A
    Sangre (Barc); 1999 Feb; 44(1):38-43. PubMed ID: 10323095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV retrospective study of the German Red Cross blood donation service in Germany].
    Glück D; Elbert G; Dengler T; Gossrau E; Grässmann W; Grimm M; Holzberger G; Sternberger J; Weise W; Kubanek B
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):368-75. PubMed ID: 7873915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Health status of blood donors in the Magdeburg region (1974-1980)].
    Brandstädter W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):843-8. PubMed ID: 6187636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of paid whole and plasma donation.
    Kretschmer V; Weippert-Kretschmer M; Slonka J; Karger R; Zeiler T
    Dev Biol (Basel); 2005; 120():101-11. PubMed ID: 16050162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current issues in transfusion medicine in Norway.
    Flesland O; Seghatchian J
    Transfus Apher Sci; 2005 Feb; 32(1):7-10. PubMed ID: 15737866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Costs of safety of blood and blood products].
    Seifried E; Soedel G
    Zentralbl Chir; 1995; 120(8):584-92. PubMed ID: 7571889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of blood donation history of people with HIV infection to identify recipients at risk.
    Gill MJ; Meyers G; Rajwani A
    CMAJ; 1994 Oct; 151(8):1147-51. PubMed ID: 7922946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Collection and utilization of plasma in Austria: on the way to national self-sufficiency].
    Bergmann H; Lukas M; Prusa P
    Beitr Infusionsther Transfusionsmed; 1996; 33():103-10. PubMed ID: 8974681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a national all voluntary blood transfusion service by adequate blood component therapy cover actual and future needs of albumin?
    Barker LF; Cazal P; Haussman HG; Hollán S; Kellner A; Lundsgaard-Hansen P; Schiff P
    Vox Sang; 1976; 31?-73(3):225-38. PubMed ID: 969394
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional and temporal variation in American Red Cross blood donations, 1995 to 2005.
    Crawford SO; Reich NG; An MW; Brookmeyer R; Louis TA; Nelson KE; Notari EP; Trouern-Trend J; Zou S
    Transfusion; 2008 Aug; 48(8):1576-83. PubMed ID: 18503618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
    Cable R; Musavi F; Notari E; Zou S;
    Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How much blood is needed?
    Seifried E; Klueter H; Weidmann C; Staudenmaier T; Schrezenmeier H; Henschler R; Greinacher A; Mueller MM
    Vox Sang; 2011 Jan; 100(1):10-21. PubMed ID: 21175652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selection of donors in multicomponent collection management.
    Bonomo P; Garozzo G; Bennardello F
    Transfus Apher Sci; 2004 Feb; 30(1):55-9. PubMed ID: 14746822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A retrospective study of the practice of "look-back" procedures, on the incidence of HIV-1/2-positive blood donors and the risk of transfusion-associated HIV infection in public-community blood banks in Germany].
    Zeiler T; Kretschmer V; Sibrowski W
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):362-7. PubMed ID: 7873914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.